Baco Pharm Private Limited
Baco Pharm Private Limited is a Private Indian company incorporated in 1987 and based in Maharashtra, India. Baco Pharm Private Limited operates in Pharmaceuticals & Chemicals (NIC 24110) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Explore the complete profile of Baco Pharm Private Limited, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Baco Pharm Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +37d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Baco Pharm Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 699643181 | ICICI Bank Ltd(Bank) | ₹20.27 Cr | 27 Jan 2023 | Open |
| 823140365 | ICICI Bank Ltd(Bank) | ₹17.49 Cr | 27 Jan 2020 | Satisfied |
| 980083441 | ICICI Bank Ltd(Bank) | ₹1.54 Cr | 27 Jan 2020 | Open |
| 273523678 | ICICI Bank Ltd(Bank) | ₹10.44 Cr | 12 Mar 2020 | Satisfied |
| 242223073 | State Bank of India(Bank) | ₹13.12 Cr | 27 Jan 2019 | Open |
| 751720540 | Kotak Mahindra Bank Ltd(Bank) | ₹4.57 Cr | 04 Jul 2019 | Satisfied |
Charge IDs, lenders & amounts for Baco Pharm Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹7.78 Cr | ₹18.17 L | ₹3.70 Cr | ₹10.73 Cr | 306 |
| FY2023-24 | ₹7.10 Cr | ₹10.79 L | ₹6.05 Cr | ₹9.01 Cr | 351 |
| FY2022-23 | ₹4.85 Cr | ₹21.44 L | ₹4.04 Cr | ₹7.03 Cr | 34 |
| FY2021-22 | ₹6.24 Cr | ₹4.94 L | ₹2.82 Cr | ₹8.46 Cr | 114 |
Audited financials & ratios for Baco Pharm Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹7.78 Cr | ₹7.10 Cr | ₹4.85 Cr | ₹6.24 Cr |
| Other income | ₹9.35 L | ₹3.72 L | ₹7.02 L | ₹12.15 L |
| Total income | ₹7.87 Cr | ₹7.14 Cr | ₹4.92 Cr | ₹6.36 Cr |
| Total expenses | ₹7.64 Cr | ₹7.00 Cr | ₹4.65 Cr | ₹6.30 Cr |
| Profit before tax | ₹23.62 L | ₹14.02 L | ₹27.88 L | ₹6.42 L |
| Profit / (Loss) after tax | ₹18.17 L | ₹10.79 L | ₹21.44 L | ₹4.94 L |
| Balance sheet | ||||
| Equity / Net worth | ₹3.70 Cr | ₹6.05 Cr | ₹4.04 Cr | ₹2.82 Cr |
| Borrowings | ₹3.70 Cr | ₹1.26 Cr | ₹1.28 Cr | ₹1.20 Cr |
| Current liabilities | ₹3.90 Cr | ₹1.26 Cr | ₹1.26 Cr | ₹2.44 Cr |
| Total liabilities | ₹7.03 Cr | ₹2.96 Cr | ₹2.99 Cr | ₹5.64 Cr |
| Current assets | ₹5.14 Cr | ₹5.05 Cr | ₹2.88 Cr | ₹4.79 Cr |
| Cash & equivalents | ₹1.70 Cr | ₹1.27 Cr | ₹74.64 L | ₹1.54 Cr |
| Total assets | ₹10.73 Cr | ₹9.01 Cr | ₹7.03 Cr | ₹8.46 Cr |
| Employees | 306 | 351 | 34 | 114 |
Audited financials & ratios for Baco Pharm Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹7.78 Cr | -7.2% | -0.6% | +7.8% |
| Profit after Tax | ₹18.17 L | +33.7% | -3.6% | +1.8% |
| Net Worth | ₹3.70 Cr | +2.8% | +12.2% | +2.7% |
| Employees | 306 | +22.2% | +14.0% | +10.5% |
Audited financials & ratios for Baco Pharm Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹7.78 Cr | ₹18.17 L | +2.34% | +8.62% | +4.91% | +1.69% | 1.00 | ₹2.54 L |
| FY2023-24 | ₹7.10 Cr | ₹10.79 L | +1.52% | +15.66% | +1.78% | +1.20% | 0.21 | ₹2.02 L |
| FY2022-23 | ₹4.85 Cr | ₹21.44 L | +4.42% | +34.48% | +5.31% | +3.05% | 0.32 | ₹14.28 L |
| FY2021-22 | ₹6.24 Cr | ₹4.94 L | +0.79% | +25.67% | +1.75% | +0.58% | 0.43 | ₹5.48 L |
Audited financials & ratios for Baco Pharm Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 55,80,072 | 55.91% |
| Institutional Investors | 1 | 4,64,597 | 4.66% |
| Public & Others | 34 | 39,35,901 | 39.44% |
Promoter, institutional & public holding for Baco Pharm Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
97 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.